Post by
inviolablspirit on Nov 18, 2024 8:59pm
Pharmala
I've noticed that there is very little to no coverage of Pharmala. It's not on any stock pick lists or in newslettters. Even when you come across a Canadian top-performing list of junior biotech or pharmaceutical companies, Pharmala is no where to be found or mentioned. Yet, they top almost evey company on the list in % performance this year. So there is a lot more potential movement in this stock in the coming months and years, as it gets noticed.
I don't mind this stock continuing to move up whille still being relatively unknown. That will eventually change. And once the stock gets over that 50 cent mark it will get rid of those half penny asks/bids, then it needs to get over that dollar mark for it to really get on the radar of most institutions. As many institutional portfolios have rules that don't allow adding stocks below the $1.00 mark. When stocks get into that $2.50 - $3.00 range that's where institutional investing really begins and positions are taken. Unfortunately for most retail investors, that's when most have sold off their investment. However, there's nothing wrong with solidifying your profits and possible retirement.